# The Clinical Application of Tauroursodeoxycholic Acid in Patients With Liver Fibrosis.

> **NCT04727320** · EARLY_PHASE1 · UNKNOWN · sponsor: **The First Affiliated Hospital with Nanjing Medical University** · enrollment: 60 (estimated)

## Conditions studied

- Liver Cirrhosis

## Interventions

- **DRUG:** Tauroursodeoxycholic acid
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04727320
- **Lead sponsor:** The First Affiliated Hospital with Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-03-05
- **Primary completion:** 2021-07-30
- **Final completion:** 2021-07-30
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04727320

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04727320, "The Clinical Application of Tauroursodeoxycholic Acid in Patients With Liver Fibrosis.". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04727320. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*